Introduction
The characterization of coronary lesions precursors of acute events remains the holy grail of intra-coronary imaging. 1, 2 The characteristics of coronary plaques have been scrutinized to understand characteristics related to the hazard of subsequent cardiovascular events. [2] [3] [4] Traditionally, a plaque with a fibrous cap (FC) thickness <65 lm on top of a necrotic core is nominated thin cap fibroatheroma (TCFA) and is considered as a high risk plaque. Optical coherence tomography (OCT) is an intra-vascular lightbased imaging method with a near-histological resolution of 10-20 mm. Currently, OCT is the only technology available in the clinical setting that provides spatial resolution sufficient to assess FC thickness accurately (FCT). 5, 6 Consequently, OCT has been used to study the ability of pharmacological or interventional therapies to promote FC thickening (i.e. plaque stabilization). 7, 8 However, in natural history studies, OCT has been used only to assess coronary fibroatheromas as a 2D structure and sometimes the assessment is only perform in a single frame. 7, 8 This approach is very limited and is not able to pick up changes that may occur in other dimensions. The recently developed optical frequency domain imaging (OFDI) technique, an analogue of the Fourier-domain OCT, is the state-of-the-art of this technology. Accordingly, we sought to describe the changes of coronary fibroatheromas over a 6-month follow-up period, describing the serial volumetric modifications of the FC as determined by OCT.
Methods

Study population
The TROFI (Thrombus Aspiration on Flow Area in Patients with ST-Elevation Myocardial Infarction; ClinicalTrials.gov Identifier: NCT01271361) trial has been described in details previously. 9, 10 In brief, the TROFI trial prospectively randomized STEMI patients to receive either primary percutaneous coronary intervention (PCI) with thrombectomy (n = 71) or without thrombectomy (n = 70) prior to biolimus-A9 eluting metallic stent (Nobori V R , Terumo Europe N.V., Leuven, Belgium) implantation. STEMI patients having an angiographically visible stenosis (>30%) or pre-procedural TIMI flow grade < _2 in a single de novo, native, unstented vessel were considered for enrolment. The study protocol was approved by the local ethics committees at each of the five European participating centres, and written informed consent was obtained from all enrolled patients.
OFDI acquisition
The present study included OFDI data regardless of the randomization arm. After the post-procedural angiography, OFDI image acquisition was performed with the TERUMO OFDI system (Terumo Europe N.V., Leuven, Belgium) with imaging element rotating at 9600 rpm allowing imaging at 160 frames/s. Intra-coronary nitroglycerin (0.2 mg) was administered before the OFDI acquisition. An automated OFDI pullback with a speed of 20 mm/s was performed during continuous intra-coronary injection of 100% contrast medium using an injection pump at a pressure of 300 p.s.i. with a flow rate of 3-4 ml/s for a maximum of 4 s or manually. Imaging calibration was performed as previously described. 11 At 6-month follow-up the same OFDI console and acquisition methodology was used in the infarct related coronary artery.
Off-line OFDI analysis
The OFDI raw data were transformed from the original 16 bits polar image to an 8 bits Cartesian image of 1024 by 1024 pixels. The off-line analysis was performed using the QCU-CMS software (LKEB, Leiden University, The Netherlands). Two experienced image analysts were involved in the present evaluation. The first step was the delimitation of regions of interest (ROIs) by identifying lipid rich non-culprit lesions in the infarct related artery at the index procedure at least 5 mm distant from the implanted stent. The FC was identified as a signal-rich band overlying the lipid core. Serial OFDI images at baseline and 6-month follow-up were reviewed side by side on the screen, and ROIs were matched based on the distance from landmarks, such as branches, calcifications, and stents. The quantification of FC was done in all corresponding frames for volumetric analysis of cap thickness. After the lumen border detection in the transversal image, the operator delineated the lipid-rich sector laterally using the two rays which emanate from vertex localize in the centre of the imaging catheter ( Figure 1) . In case the guide-wire shadow was located within the defined sector, the shadow area was marked out and excluded from the analysis. Next the semi-automatic FC segmentation was applied on (transversal OCT images), and the luminal-and abluminal boundaries of the FC within the manually defined sector were extracted automatically ( Figure 1) . The detection of the FC was done using the largest gradient in pixel intensity (first derivative) between the FC tissue and the lipid region (i.e. where the slope on the sigmoid curve changes fastest). To avoid false edge information, the pixels in front of the maximum intensity in the FC region (i.e. pixels originating from the lumen), were discarded. After segmentation, the distances between the lumen and FC borders were determined allowing the computation of the minimal, maximum, and mean FC thickness within the sector. The distance was calculated by dividing the lumen contour in 1 intervals and next determine the shortest distance from each lumen point to the FC contours. The angle between the vertical axis at 12 o'clock and the position of the minimal-and maximum FC thickness was recorded. This semi-automated assessment for the minimal FCT has shown perfect agreement for both inter-and intra-observer assessments (j = 1.00) (in press report). An example of this semi-automated method is presented in Figure 1 .
The presence of TCFA was defined as a minimal FCT <65 mm in at least one frame of the longitudinal region of interest. Lesions with minimal FCT >65 mm were named thick-cap fibroatheromas (ThCFA). Lesions that were TCFAs at baseline and had FCT > 65 mm at follow-up were named Pacified TCFAs. ThCFAs that became TCFAs at follow-up were Newly TCFAs.
Data analysis
Discrete data were summarized as percent (frequencies) and were compared using the chi-squared test. Continuous data were expressed as mean ± SD or median [Inter-quartile Range (IQR)] and were compared using Student's t-test or Wilcoxon rank-sum test based on their distributions. The distribution was tested using the Kolmogorov-Smirnov test. P < 0.05 was considered statistically significant. SPSS version 21.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.
Results
Between 24th November 2010 and 11th October 2011, 141 patients (71 patients in the thrombectomy arm and 70 patients in the nonthrombectomy arm) were enrolled at five European sites. In three pre-defined centres, the enrolled patients were followed-up angiographically and with OFDI at 6 months. Paired (post-procedure and follow-up) OFDI recordings were available in 49 patients. The baseline clinical characteristics are depicted in Table 1 .
Overall changes in non-culprit lipid-rich lesions
In 34 patients (69%), a total of 58 non-culprit lipid rich lesions were found in the infarct related artery. Table 2 presents the overall changes in these regions. 1624 frames were analysed at baseline and 1596 at 6-month follow-up. It was found an overall stabilization in these lipid-rich regions ( Table 2) . The minimal FCT increased significantly from 0.07 (IQR 0.018-0.096) mm at baseline to 0.12 (IQR 0.09-0.17) mm at 6-month follow-up (P < 0.01). The number of frames with FCT smaller than 65 mm also decreases significantly (P < 0.01). The mean FCT increased 0.031 ± 0.072 mm (P < 0.01) and 
Qualitative changes of fibroatheromas
Out of 58 lesions, 34 lesions were TCFA at baseline and 30 at 6-month follow-up. Ten lesions that were TCFA at baseline became ThCFAs at follow-up. Out of 24 lesions that were ThCFAs at baseline, six became TCFA at follow-up. Therefore, 28 lesions were ThCFA at 6-month follow-up ( Figure 3 ). An example of the natural history of fibroatheromas is given in Figure 4 .
Vulnerable plaques at follow-up
All the lesions that were TCFAs at 6-month (n = 30) had similar FC volume at baseline and follow-up (P = 0.37) ( Table 3) . There was, however, a significant increase in the mean FCT (P = 0.03) and a 0.85 ± 2.10 mm decrease in the lesion length (P = 0.03). There was also a trend to reduction in the number of frames with FCT <65 mm (P = 0.06).
Plaque stabilization vs. plaque refractoriness: comparison of baseline characteristics
At baseline, Pacified TCFAs had different OFDI findings as compared with lesions that remained TCFAs ( Table 4 ; Figure 5 ). The maximal and the mean FCT were significantly larger in Pacified TCFAs (P = 0.01 for both). Pacified TCFAs has also a trend to have less frames with Cap thickness <65 mm. The cap volume was not different (P = 0.69).
All the lesions that were ThCFAs at follow-up demonstrated an increase of 0.030 ± 0.059 mm in the mean FCT (P = 0.01), a decrease of Figure 1 Representation of fibrous cap (FC) measurement. (A) Two analysts identified non-culprit, lipid-rich plaques at baseline. Thereafter, using anatomic landmarks, the two analysts found correspondent lesions at follow-up. (B) (1 and 2) the first step is lumen border detection; (3) Secondly, the guidewire artefact is masked to avoid interference; (4) the software detects the FC by using the largest gradient in pixel intensity; (5) identification of minimal FC thickness (white arrow); mean FC thickness (green line); maximal FC thickness (yellow arrow); (C) The same steps are repeated in all frames involved in that region of interest. OFDI, optical frequency domain imaging; STEMI, ST elevation myocardial infarction; TCFA, thin-cap fibroatheroma.
. 
Discussion
The main findings of the present study can be summarized as follows: (i) Lipid-rich, non-culprit lesions was frequently found (69% of the patients) in infarct related coronary arteries in STEMI patients; (ii) there was an overall reduction in fibrous-cap volume after 6 months mostly driven by shortening of the lesion length; (iii) 27% of lesions changed their phenotype (TCFAs or ThCFAs) over time; (iv) Pacified TCFAs had different plaque characteristics at baseline as compared with lesions that remained TCFAs.
The precise identification of plaques that are prone to rupture and cause a major coronary event is a field of major clinical relevance. In this regard OCT is the only clinically available method with enough resolution to measure the FCT in vivo accurately. Although TCFAs as visualized by OCT are often diagnosed with confidence, some factors may preclude a correct diagnosis: those involving the qualitative classification (identification of a FAs) and those concerning the measurement of the FC with the aim to distinguish TCFAs from ThCFAs. 12, 13 The present work used a fully automatic FC volumetric assessment by OCT, a method that has shown to have a much more robust measurement than the manual assessment done by experienced analysts. 14 Another important aspect of imaging of coronary fibroatheromas is to assess their temporal changes and correlations with clinical factors, laboratory findings, and therapeutics agents. Factors such as high circulating neopterin (a pteridine derivative secreted by activated macrophages), low eicosapentaenoic acid/arachidonic acid ratio, current smoking, low-density lipoprotein and presentation with acute coronary syndrome have been correlated with thinner FC thickness by OCT or the presence of TCFAs. 15 atorvastatin therapy (20 mg/day) has shown to increase the FC thickness in coronary plaques as compared with 5 mg/day. 8 In addition, PCIs with bioresorbable scaffolds or metallic stents have been tested to passivate vulnerable plaques over time with promising results. 7, 18, 19 However, these invasive strategies still do not have evidence strong enough to be implemented in the clinical practice. The present work describes, for the first time, the volumetric temporal changes of FC by OFDI and can be used in future investigations of natural history of coronary atherosclerosis. It has to be highlighted that it was found 58 non-culprit fibroatheromas in the target vessel of 49 STEMI patients (1.2 lesions/patients). Moreover, 34 fibroatheromas were quantified as TCFAS at baseline (1.0/patient). Galon et al., using a similar semi-automatic algorithm for FC assessment, have also found a considerable number of non-culprit Figure 4 Temporal changes of three fibroatheromas in the same patient matched for the index procedure and 6-month follow-up. A 2D map, color-coded by the fibrous cap thickness is given. There are better OFDI characteristics in all lesions. The X axis represents the distance from the distal to proximal segment of the coronary artery, while the Y axis represents the circumferential segment (angle). The Lesions 1 and 2 were thin-cap fibroatheromas (TCFA) that became a Pacified TCFA 6 months later. The lesion 3 was found to be ThCFA in the two acquisitions. It has to be highlighted that the frames where the minimal thickness were located were different between the two time points.
Serial volumetric assessment of coronary fibroatheroma
fibroatheromas in the target vessel of 18 STEMI patients (2.11 lesions/patient). 20 In their work however the overall minimal and mean cap thickness were about the half of the value we found in the present work (0.032 ± 0.017 mm vs. 0.070 and 0.144 ± 0.027 vs. 0.288 ± 0.070, respectively). Besides the relatively small sample sides, as abovementioned, patients' individual characteristics may have influenced these discrepancies. The concept of the FC volume is an important message of the present work. In a lipid-rich lesion, the FC cloisters the atheroma, maintaining it away from the coronary circulation. Thus, the FC is an indirect measure of the total lipid burden by OCT. Therefore, the observed decrease in the FC volume is a measure of the decrease in the total content of the atherosclerotic volume in these lipid-rich non-culprit coronary lesions. It has been shown in intra-vascular ultrasound studies that the coronary atheroma volume predicts MACE, despite the achievement of very low on-treatment LDL-C levels. 21 Moreover, in patients who presented with an acute coronary syndrome and underwent PCI the strongest predictor of clinical events at follow-up in the non-culprit lesion was the atherosclerotic burden. 22 Therefore, it is quite plausible that the FC volume as assessed by OCT may have prognostic implications. This, however, deserves further investigation. Another important finding of the present study is the dynamic nature of the fibroatheromas. There was an overall improvement of these non-culprit plaques with significant increase of the minimal and mean FCT with reduction of the FC angle, lesion length and cap volume (P < 0.01 for all). However, when these lesions were classified qualitatively (TCFAs or ThCFAs) 27% changed their phenotype over time and TCFAs still were present in a sizeable proportion (58% at baseline and 51% at 6-month follow-up ( Figure 3) . However, the remaining TCFAs at 6-month also had signals of improvement with shorter lesion length and larger mean cap thickness (Table 3) . Importantly, it was shown that the regions where the minimal FC was found in each lesion may change over time (Figure 4) . Interestingly, pacified TCFAs had larger mean and maximum FC as compared with plaques that remained TCFAs over time ( Table 4) . The clinical explanation and prognostic implications of these quantitative measurements still have to be investigated.
Limitations
The TROFI trial was design to investigate the role of thrombectomy on improving the flow are in STEMI patients. Therefore, the clinical explanations (e.g. lipid control, pharmacological adherence, etc.) for plaque phenotype modifications over time could not be explored. As abovementioned, the relatively small sample size does not allow for explore the prognostic implications of FC volume change still have to be established. Additionally, the present methodology does not take into account the presence of OCT signal intensity that may be correlated with the presence of macrophages which may be a contributor to atherosclerotic plaque instability. 23 Nonetheless, we demonstrated for the first time a serial description of a volumetric quantification of FC which allows for investigation of the natural history of high-risk coronary plaques.
Conclusion
Non-culprit fibroatheromas located in the infarct related artery of patients with STEMI had a volumetric reduction of the FC after 6-month follow-up. Quantitative FC assessment was able to differentiate high-risk lesions that became ThCFAs. There was a considerable change of plaque phenotype (TCFAs or ThCFAs) over time. 
